David Karner

Background

About David Karner

We shape the future of Cannabis in Germany! In recent years, cannabis has been used in medicine with great therapeutic success. More and more patients are benefiting from the medical benefits of THC and CBD in the treatment of chronic pain and disease. Yet this type of therapy still faces many obstacles in the German market! As for example: 1. The continuing stigmatization of cannabis. A lack of comprehensive educational offers for professionals. Approval reservations for the assumption of costs for patients by health insurances. Access difficulties for patients connected with high bureaucratic expenditure. For these reasons, Markus Musiol and I decided to holistically tap into the fast-growing cannabis market in Germany & founded enua in 2018! Our vision: Providing sustainable access to cannabis for patience! Our EU-GMP licensed company collaborates with award-nominated genetics banks and offers a broad product portfolio from established partners. This allows us to provide our customers & partners with high quality cannabis. Beyond sales, we want to help (future) customers, patients, doctors and pharmacists to get an overview of the broad cannabis landscape. Next step: The federal government's legalization plans opened up new opportunities. Thus we want to actively take part in shaping the changing market & industry and are preparing for the recreational market development. If you want to learn more about the potential, the application fields of cannabis & about the upcoming legalization or are you interested in a collaboration-> Drop me a message here on LinkedIn or check out https://enua.de/